COVID-19 in Russia: Epidemiology and Molecular Genetic Monitoring

Abstract

Background. The COVID-19 pandemic has exposed health problems, but at the same time has become a powerful impetus for the development of new scientific research in the field of epidemiology, clinic of infectious diseases, diagnostics, bioinformatics and digital methods. On the basis of the Central Research Institute of Epidemiology of Rospotrebnadzor, new unique test systems for the detection of SARS-CoV-2 RNA based on real-time PCR based on loop isothermal amplification (IT) technology have been developed, which allows you to examine samples 34 times faster than those developed previously. The Central Research Institute of Epidemiology of Rospotrebnadzor has developed and put into operation the Russian Platform for Aggregation of Information on Virus Genomes (VGARus). The VGARus database contains information about the nucleotide sequences of the SARS-CoV-2 viruses and their mutations, and the SOLAR Integration Platform has been created to quickly transfer the results of PCR studies to all interested citizens of the Russian Federation.
 Aims to study the manifestations of the epidemic process of COVID-19 and the prevalence of genovariants of the SARS-CoV-2 virus in the Russian Federation.
 Methods. A retrospective epidemiological analysis of the incidence of COVID-19 was carried out from March 30, 2020 to May 17, 2022 in the Russian Federation. The database was formed on the basis of the materials of the Rospotrebnadzor report form No. 970 Information on cases of infectious diseases in persons with suspected new coronavirus infection, data from the WHO, the domestic information portal Stopkoronavirus.rf and the Yandex DataLens data visualization and analysis service were used, information on SARS-CoV-2 genovariants in the VGARus database.
 Results. When analyzing the manifestations of the COVID-19 epidemic process in the Russian Federation for 20202022. Two stages have been identified. The first stage was characterized by the rapid spread of the SARS-CoV-2 virus from megacities to other regions of the country and the use of non-specific prevention measures. The beginning of the second was due to the evolution of the SARS-CoV-2 virus and a change in its biological properties, followed by a change in the prevailing genovariants on the territory of the Russian Federation.
 Conclusion. As a result of the study, it was found that with each subsequent increase in the incidence of COVID-19, there was a decrease in the severity of the course and the proportion of pneumonia in the structure of the clinical forms of the disease.

Development and Application of Real-Time PCR-Based Screening for Identification of Omicron SARS-CoV-2 Variant Sublineages

“…However, the next-generation sequencing approach can be quite laborious, it requires expensive equipment and reagents, it may take a long time, and new methods for faster and cheaper genotyping are also being developed to overcome these limitations [ 10 ]. At the same time, the strategy of using fragment sequencing (e.g., Sanger sequencing) or screening methods for virus subtype classification has also been successful in some instances [ 11 , 12 ].…”

Mri of the Chest in Assessing the Severity of Pulmonary Arterial Hypertension in Patients Underwent Covid-19

“…Лучевая диагностика и терапия / Diagnostic Radiology and Therapy Введение COVID-19, составляющий до сих пор, как многократно отмечалось [1,2], не только общемедицинскую, но и социальную проблему, к сожалению, не исчерпывается эпизодом острого заболевания, а приводит к многочисленным постковидным нарушениям со стороны собственно легких [3], головного мозга [4], миокарда [3,5]. Несмотря на явное падение первичной заболеваемости и фактическую победу над этой эпидемией в России, исходы и осложнения COVID-19, вплоть до летальных, по-прежнему ухудшают картину общей смертности в РФ.…”

Features of the clinical course of COVID-19 in people living with HIV

“…Начальный период пандемии характеризовался циркуляцией, в том числе на территории Российской Федерации, вирусов SARS-CoV-2, принадлежащих к генетической линии В.1.1. SARS-CoV-2 (PАNGO), на смену которым в апреле пришли представители новых генетических групп 20I (Alpha) и 21J (Delta) [2,3]. Для клинического течения новой коронавирусной инфекции COVID-19 первых 2 волн было характерно спонтанное развитие заболевания c широким спектром клинических проявлений -от бессимптомного до быстрого прогрессирования в тяжелую форму с развитием молниеносной пневмонии, дыхательной недостаточности и смерти [4][5][6].…”